Articles

Poll

Podcasts

Slideshows

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

The post-hoc analysis found tenapanor significantly improved weekly scores for abdominal pain, discomfort, and bloating, as measured by the Abdominal Score.

Tenapanor Significantly Reduces Key Abdominal Symptoms in Patients with IBS-C

Test your knowledge of the AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases with this clinical quiz!

Clinical Quiz: AGA Guideline for Fecal Microbiota-Based Therapies in Gastrointestinal Disease

Our February 2024 month in review highlights EoE pipeline news, new FMT guidelines, and research about endoscopic inflammation and disease activity in IBD.

Gastroenterology Month in Review: February 2024

Investigators from the guideline panel discuss the AGA’s recommendations regarding the use of fecal microbiota-based therapies for CDI, IBD, and IBS.

Experts’ Perspectives: AGA Recommends FMT for C Diff

The guideline recommends fecal microbiota transplant in most cases of recurrent Clostridioides difficile infection but does not suggest fecal microbiota-based therapies for IBD or IBS.

AGA Supports Fecal Microbiota-Based Therapies for C Diff in New Guideline

Adhering to a greater number of healthy lifestyle behaviors was linked to a decreased risk of incident IBS, suggesting lifestyle modifications may help prevent its onset.

Engaging in More Healthy Lifestyle Behaviors May Reduce Risk of IBS

The new data was published in The Lancet Gastroenterology & Hepatology and highlighted additional efficacy endpoints from the study used to support linaclotide’s FDA approval in 2023.

New Phase 3 Data Reinforces Safety, Efficacy of Linaclotide for Pediatric Functional Constipation

Pretreatment vitamin D levels were associated with endoscopic improvement in patients with UC and decreased C-reactive protein levels in patients with CD.

Vitamin D Linked to Clinical, Endoscopic Outcomes of Vedolizumab Treatment for IBD

New QUASAR analysis shows patients with intolerance or failed response to advanced therapies nonetheless achieved benefit with guselkumab.

Guselkumab Benefits Ulcerative Colitis Regardless of Patient Treatment History

The investigator discusses the unique interplay between conditions like IBD and gestational risks—and how specialists need to improve communication.

Uma Mahadevan, MD: Prioritizing Gastric Health in Gestational Patients

On the HCPLive irritable bowel syndrome page, resources on the topics of medical news and expert insight into IBS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBS, IBD, and more.

Irritable Bowel Syndrome